Our Mission
Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes.
Biogen is convinced that biosimilars are central to securing future innovation in healthcare. Biogen's current portfolio of biosimilars includes a number of indications within immunology (also known as immune-mediated inflammatory diseases).